Projected Prostate Cancer Rates in Patients Living With HIV
Posted: Monday, August 13, 2018
Prostate and lung cancers are projected to be the most common cancer types among people living with HIV by 2030, according to study findings published in the Annals of Internal Medicine. However, the study investigators found the age-specific rates are projected to decrease through 2030 across age groups for Kaposi sarcoma and non-Hodgkin lymphoma in this population.
“Although the total burden of cancer among [people living with HIV] is expected to decrease by 18%, cancer will remain an important comorbid condition, and tailored public health programs focused on cancer prevention, screening, and treatment in [people living with HIV] are needed,” concluded lead author Meredith S. Shiels, PhD, MHS, of the National Cancer Institute, and colleagues.
Researchers used data from the National Cancer Institute’s HIV/AIDS Cancer Match Study and the HIV Optimization and Prevention Economics model to project cancer incidence rates through 2030. Populations were stratified by age and AIDS-defining cancer or non–AIDS-defining cancer (with other cancer types combined).
The projected proportion of adults aged 65 and older living with HIV in the United States is predicted to increase from 8.5% in 2010 to 21.4% in 2030, whereas the estimated total cancer burden is projected to decrease from 8,150 cases in 2010 to 6,690 cases in 2030. However, by 2030, prostate cancer, with 1,590 cases, is projected to be the most common cancer type. That represents the largest increase (n = 840) of any cancer type from 2010 to 2030.
